Completed PHASE3 INTERVENTIONAL 1-arm NCT01411189

Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Sponsor: Nihon Pharmaceutical Co., Ltd

Conditions Colon Nos Polypectomy Tubular Adenoma Gastric Adenoma Gastric Cancer

Interventions Menthol

Updated 5 times since 2017 Last updated: Jun 27, 2012 Started: Sep 30, 2011 Primary completion: May 31, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Colon Nos Polypectomy Tubular Adenoma and Gastric Adenoma, this trial is completed. The trial is conducted by Nihon Pharmaceutical Co., Ltd and has accumulated 5 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nihon Pharmaceutical Co., Ltd

Data source: Nihon Pharmaceutical Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tokyo, Japan